Climara vs. Divigel

See how Climara and Divigel compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Climara is a once-weekly patch, while Divigel is a once-daily gel, so the main practical difference is how often estradiol needs to be applied.

  • Climara offers six patch-dose strengths and covers more FDA-approved uses, including osteoporosis prevention and vaginal atrophy, while Divigel is approved only for hot flashes.

  • Climara's typical monthly list price is far lower than Divigel's, which can be a deciding factor for patients paying out of pocket.

Climara vs. Divigel Drug Summary

Climara

Climara is a steroidal estrogen patch used for hormone replacement therapy. It treats moderate to severe menopausal hot flashes, vaginal atrophy, and hypoestrogenism, and it helps prevent postmenopausal osteoporosis. The patch is worn on the skin and changed once a week.

Divigel

Divigel is an estradiol gel from the same estrogen hormone-therapy class. It is FDA-approved for moderate to severe hot flashes associated with menopause and is applied once daily to the thigh. Some clinicians also use it off-label for vaginal dryness or gender-affirming therapy.

Climara vs. Divigel Side Effects

Climara

Most common
Breast pain (≥10%)
Headache (≥10%)
Abdominal pain (≥10%)
Generalized pain (≥10%)

Divigel

Most common
Metrorrhagia (>5%)
Breast tenderness (>5%)
Vaginal mycosis (>5%)
Nasopharyngitis (>5%)

Climara vs. Divigel Dosage

Climara

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.025 mg/day patch At the start
Maximum dose 0.1 mg/day patch If needed
Dose changes 5 increases As tolerated

Divigel

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 0.25 g once daily At the start
Maximum dose 1.0 g once daily If needed
Dose changes 3 increases As tolerated

Climara vs. Divigel Indications

Climara

Climara is FDA-approved for several menopause-related and hormonal conditions beyond hot flashes. It treats vulvar and vaginal atrophy, hypoestrogenism from hypogonadism or ovarian failure, and helps prevent bone loss after menopause. It is also used off-label for feminizing hormone therapy in transgender women.

  • Moderate to severe hot flashes from menopause

  • Vulvar and vaginal atrophy due to menopause

  • Hypoestrogenism from hypogonadism, castration, or ovarian failure

Divigel

Divigel's only FDA-approved use is treating moderate to severe hot flashes linked to menopause. It does not carry approved indications for osteoporosis prevention or vaginal atrophy, though clinicians sometimes prescribe it off-label for those purposes. It is also used off-label in gender-affirming hormone therapy.

  • Moderate to severe hot flashes from menopause

  • Off-label: vaginal dryness or atrophy

  • Off-label: gender-affirming hormone therapy

Climara vs. Divigel Pros and Cons

Climara

Climara's weekly patch and six dose strengths give clinicians flexibility to fine-tune estrogen levels across multiple menopause-related conditions. It is also FDA-approved for osteoporosis prevention and vaginal atrophy, uses that Divigel's label does not cover. Its list price is typically far lower than Divigel's.

Pros

  • Once-weekly application, fewer doses than a daily gel

  • Six dose strengths allow precise titration

  • FDA-approved for osteoporosis prevention and vaginal atrophy, not just hot flashes

Cons

  • Patch can cause skin irritation at the application site

  • Only available in fixed patch doses, less adjustable than a gel's variable amounts

  • Patch remains visible on the skin between changes

Divigel

Divigel's daily gel offers fine dose adjustments and is approved specifically for hot flash relief. It does not carry the broader FDA approvals for osteoporosis prevention or vaginal atrophy that Climara has. Its list price is substantially higher than Climara's patch.

Pros

  • Daily gel dosing allows small, granular dose adjustments

  • Gel absorbs quickly and leaves nothing visible on the skin

  • Simple once-daily routine with a clear, odorless gel

Cons

  • Requires daily application, more frequent than Climara's weekly patch

  • Risk of secondary exposure to children or pets after skin contact

  • No FDA-approved use for osteoporosis prevention or vaginal atrophy

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.